Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Endocrine 1 CNS 1

Conditions

Glioma 20 Glioblastoma 15 Brain Neoplasms 11 Neuroblastoma 4 Neoplasms 4 Astrocytoma 4 Sarcoma 3 Prostatic Neoplasms 2 Neurofibromatosis 1 2 Neoplastic Cells, Circulating 2 Meningioma 2 Lung Neoplasms 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Radiation Injuries 1 Polycystic Kidney, Autosomal Recessive 1 Pituitary Neoplasms 1 Pheochromocytoma 1 Parkinsonian Disorders 1 Paraganglioma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Oligodendroglioma 1 Neurofibromatosis-Noonan syndrome 1 Neurofibromatoses 1 Neoplasms, Germ Cell and Embryonal 1

Interventions

3-Iodobenzylguanidine 13 lutetium Lu 177 dotatate 5 gallium Ga 68 dotatate 4 Temozolomide 4 Specimen Handling 4 anlotinib 3 Magnetic Resonance Spectroscopy 3 Everolimus 3 pegfilgrastim 2 olaparib 2 cabozantinib 2 belzutifan 2 Radiotherapy 2 Phenoxybenzamine 2 Nivolumab 2 Granulocyte Colony-Stimulating Factor 2 Fluorodeoxyglucose F18 2 Biopsy 2 Axitinib 2 3-fluorobenzylguanidine 2 177Lu-octreotide, DOTA(0)-Tyr(3)- 2 vandetanib 1 tipifarnib 1 temsirolimus 1 talazoparib 1 spartalizumab 1 pentetreotide 1 penpulimab 1 pembrolizumab 1 pazopanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pheochromocytoma × Blood Specimen Collection × CNS × Clear all

NCT06444607 2024-11-21

HEPHESTOS

Radboud University Medical Center

Paraganglioma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡